Group One Trading, L.P. Pacira Bio Sciences, Inc. Transaction History

Group One Trading, L.P.

$2.68 Billion
Q2 2025

A detailed history of Group One Trading, L.P. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 357 shares of PCRX stock, worth $8,357. This represents 0.0% of its overall portfolio holdings.

Number of Shares

357

Previous 4,117 91.33%

Holding current value

$8,357

Previous $102,000 92.16%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$22.91 - $27.14 $86,141 - $102,046	-3,760 Reduced 91.33%	357 $8,000
Q1 2025 May 14, 2025	SELL	$18.33 - $27.25 $95,535 - $142,027	-5,212 Reduced 55.87%	4,117 $102,000
Q4 2024 Feb 14, 2025	SELL	$15.3 - $20.33 $105,845 - $140,642	-6,918 Reduced 42.58%	9,329 $175,000
Q3 2024 Nov 14, 2024	BUY	$11.7 - $28.46 $124,195 - $302,102	10,615 Added 188.48%	16,247 $244,000
Q2 2024 Aug 14, 2024	SELL	$25.5 - $31.51 $4,105 - $5,073	-161 Reduced 2.78%	5,632 $161,000
Q1 2024 May 10, 2024	BUY	$27.7 - $35.48 $97,171 - $124,463	3,508 Added 153.52%	5,793 $169,000
Q4 2023 Feb 14, 2024	SELL	$26.32 - $34.31 $69,432 - $90,509	-2,638 Reduced 53.59%	2,285 $77,000
Q3 2023 Nov 09, 2023	BUY	$30.68 - $40.09 $151,037 - $197,363	4,923 New	4,923 $151,000
Q1 2022 May 12, 2022	SELL	$60.03 - $76.49 $4,562 - $5,813	-76 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$47.97 - $62.21 $3,645 - $4,727	76 New	76 $5,000
Q3 2021 Nov 12, 2021	SELL	$54.64 - $61.3 $126,491 - $141,909	-2,315 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$59.31 - $78.82 $23,368 - $31,055	-394 Reduced 14.54%	2,315 $162,000
Q4 2020 Feb 10, 2021	BUY	$50.47 - $66.26 $35,329 - $46,382	700 Added 34.84%	2,709 $162,000
Q3 2020 Nov 12, 2020	BUY	$51.97 - $63.0 $90,999 - $110,313	1,751 Added 678.68%	2,009 $121,000
Q2 2020 Aug 13, 2020	BUY	$30.8 - $52.47 $7,946 - $13,537	258 New	258 $14,000
Q2 2019 Aug 09, 2019	SELL	$36.57 - $47.97 $197,880 - $259,565	-5,411 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$36.47 - $42.17 $113,458 - $131,190	-3,111 Reduced 36.51%	5,411 $206,000
Q4 2018 Feb 06, 2019	BUY	$41.31 - $52.16 $352,043 - $444,507	8,522 New	8,522 $367,000
Q2 2018 Aug 14, 2018	SELL	$27.5 - $39.8 $591,470 - $856,018	-21,508 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$29.98 - $46.35 $644,809 - $996,895	21,508 New	21,508 $670,000
Q4 2017 Feb 09, 2018	SELL	$31.85 - $46.95 $331,972 - $489,359	-10,423 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$35.7 - $39.5 $372,101 - $411,708	10,423	10,423 $391,000

Others Institutions Holding PCRX

# of Institutions

258

Shares Held

51.2M

Call Options Held

289K

Put Options Held

130K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.07B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Pacira Bio Sciences, Inc. Transaction History